166 related articles for article (PubMed ID: 35227606)
1. Cost-effectiveness of population-wide genomic screening for Lynch syndrome in the United States.
Guzauskas GF; Jiang S; Garbett S; Zhou Z; Spencer SJ; Snyder SR; Graves JA; Williams MS; Hao J; Peterson JF; Veenstra DL
Genet Med; 2022 May; 24(5):1017-1026. PubMed ID: 35227606
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States.
Guzauskas GF; Garbett S; Zhou Z; Spencer SJ; Smith HS; Hao J; Hassen D; Snyder SR; Graves JA; Peterson JF; Williams MS; Veenstra DL
JAMA Netw Open; 2020 Oct; 3(10):e2022874. PubMed ID: 33119106
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of genetic diagnostic strategies for Lynch syndrome in Italy.
Pastorino R; Basile M; Tognetto A; Di Marco M; Grossi A; Lucci-Cordisco E; Scaldaferri F; De Censi A; Federici A; Villari P; Genuardi M; Ricciardi W; Boccia S
PLoS One; 2020; 15(7):e0235038. PubMed ID: 32609729
[TBL] [Abstract][Full Text] [Related]
4. Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population.
Cenin DR; Naber SK; Lansdorp-Vogelaar I; Jenkins MA; Buchanan DD; Preen DB; Ee HC; O'Leary P
J Gastroenterol Hepatol; 2018 Oct; 33(10):1737-1744. PubMed ID: 29645364
[TBL] [Abstract][Full Text] [Related]
5. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C
Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States.
Spencer SJ; Jones LK; Guzauskas GF; Hao J; Williams MS; Peterson JF; Veenstra DL
J Clin Lipidol; 2022; 16(5):667-675. PubMed ID: 35961838
[TBL] [Abstract][Full Text] [Related]
7. Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives.
Salikhanov I; Heinimann K; Chappuis P; Buerki N; Graffeo R; Heinzelmann V; Rabaglio M; Taborelli M; Wieser S; Katapodi MC
J Med Genet; 2022 Sep; 59(9):924-930. PubMed ID: 34782441
[TBL] [Abstract][Full Text] [Related]
8. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.
Ladabaum U; Wang G; Terdiman J; Blanco A; Kuppermann M; Boland CR; Ford J; Elkin E; Phillips KA
Ann Intern Med; 2011 Jul; 155(2):69-79. PubMed ID: 21768580
[TBL] [Abstract][Full Text] [Related]
9. A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.
Snowsill T; Huxley N; Hoyle M; Jones-Hughes T; Coelho H; Cooper C; Frayling I; Hyde C
Health Technol Assess; 2014 Sep; 18(58):1-406. PubMed ID: 25244061
[TBL] [Abstract][Full Text] [Related]
10. Population Genomic Screening for Three Common Hereditary Conditions : A Cost-Effectiveness Analysis.
Guzauskas GF; Garbett S; Zhou Z; Schildcrout JS; Graves JA; Williams MS; Hao J; Jones LK; Spencer SJ; Jiang S; Veenstra DL; Peterson JF
Ann Intern Med; 2023 May; 176(5):585-595. PubMed ID: 37155986
[TBL] [Abstract][Full Text] [Related]
11. Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis.
Gallego CJ; Shirts BH; Bennette CS; Guzauskas G; Amendola LM; Horike-Pyne M; Hisama FM; Pritchard CC; Grady WM; Burke W; Jarvik GP; Veenstra DL
J Clin Oncol; 2015 Jun; 33(18):2084-91. PubMed ID: 25940718
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of routine screening for Lynch syndrome in colorectal cancer patients up to 70 years of age.
Leenen CH; Goverde A; de Bekker-Grob EW; Wagner A; van Lier MG; Spaander MC; Bruno MJ; Tops CM; van den Ouweland AM; Dubbink HJ; Kuipers EJ; Dinjens WN; van Leerdam ME; Steyerberg EW
Genet Med; 2016 Oct; 18(10):966-73. PubMed ID: 26938782
[TBL] [Abstract][Full Text] [Related]
13. The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.
Kang YJ; Killen J; Caruana M; Simms K; Taylor N; Frayling IM; Snowsill T; Huxley N; Coupe VM; Hughes S; Freeman V; Boussioutas A; Trainer AH; Ward RL; Mitchell G; Macrae FA; Canfell K
Med J Aust; 2020 Feb; 212(2):72-81. PubMed ID: 31595523
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan.
Chen YE; Kao SS; Chung RH
PLoS One; 2016; 11(8):e0160599. PubMed ID: 27482709
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
16. Fourfold increased detection of Lynch syndrome by raising age limit for tumour genetic testing from 50 to 70 years is cost-effective.
Sie AS; Mensenkamp AR; Adang EMM; Ligtenberg MJL; Hoogerbrugge N
Ann Oncol; 2014 Oct; 25(10):2001-2007. PubMed ID: 25081898
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting.
Snowsill TM; Ryan NAJ; Crosbie EJ; Frayling IM; Evans DG; Hyde CJ
PLoS One; 2019; 14(8):e0221419. PubMed ID: 31469860
[TBL] [Abstract][Full Text] [Related]
18. Which Lynch syndrome screening programs could be implemented in the "real world"? A systematic review of economic evaluations.
Di Marco M; DAndrea E; Panic N; Baccolini V; Migliara G; Marzuillo C; De Vito C; Pastorino R; Boccia S; Villari P
Genet Med; 2018 Oct; 20(10):1131-1144. PubMed ID: 29300371
[TBL] [Abstract][Full Text] [Related]
19. Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome.
Wang G; Kuppermann M; Kim B; Phillips KA; Ladabaum U
Am J Manag Care; 2012 May; 18(5):e179-85. PubMed ID: 22694112
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of screening strategies for Lynch syndrome.
Barzi A; Sadeghi S; Kattan MW; Meropol NJ
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
